Literature DB >> 7492301

Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct.

D J McCool1, J F Forstner, G G Forstner.   

Abstract

We have shown previously [McCool, Forstner and Forstner (1994) Biochem. J. 302, 111-118] using pulse-chase labelling of mucin with [3H]threonine that LS180 colonic tumour cells synthesize and secrete MUC2 without the addition of secretagogues. Treatment of the LS180 cells with monensin to disrupt Golgi function was also found to inhibit baseline secretion almost completely. In this paper we show that addition of nocodazole to inhibit microtubule assembly reduced baseline secretion by 53% over a 6 h chase period. In contrast, cytochalasin D did not affect the rate of unstimulated mucin synthesis or secretion, suggesting that baseline secretion is not influenced by disruption of actin microfilaments. In addition, regulated mucin secretion by LS180 cells was studied in response to carbachol, phorbol 12-myristate 13-acetate and A23187. Mucin released in response to secretagogues behaved identically on SDS/PAGE to that secreted under baseline conditions. T84 cells and the B6 subclone of the HT29 cell line responded in a similar manner to LS180 cells and secreted high-molecular-mass mucin which included MUC2 and behaved like LS180 mucin on SDS/PAGE. Neither monensin nor nocodazole significantly affected secretagogue-stimulated mucin secretion. Since these compounds inhibited secretion of labelled mucin under baseline conditions, mucin released by secretagogues must have come from a separate, unlabelled mucin pool in stored granules. Cytochalasin D, on the other hand, caused the release of small amounts of stored mucin, suggesting that actin microfilaments participate in regulated exocytosis. Thus two kinds of mucin secretion occur in LS180 cells. Unregulated secretion depends upon continuous transport of mucin granules from Golgi vesicles to the cell surface and does not utilize stored mucin, whereas regulated secretion involves the release of mucin from storage granules and is not affected by microtubule or Golgi disruption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492301      PMCID: PMC1136235          DOI: 10.1042/bj3120125

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Human intestinal goblet cells in monolayer culture: characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line.

Authors:  T E Phillips; C Huet; P R Bilbo; D K Podolsky; D Louvard; M R Neutra
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

2.  Cytoskeleton of intestinal goblet cells: role of microtubules in baseline secretion.

Authors:  M G Oliver; R D Specian
Journal:  Am J Physiol       Date:  1991-06

3.  Cytoskeleton of intestinal goblet cells: role of actin filaments in baseline secretion.

Authors:  M G Oliver; R D Specian
Journal:  Am J Physiol       Date:  1990-12

4.  Cytoarchitectural reorganization of rabbit colonic goblet cells during baseline secretion.

Authors:  K A Radwan; M G Oliver; R D Specian
Journal:  Am J Anat       Date:  1990-12

Review 5.  Functional biology of intestinal goblet cells.

Authors:  R D Specian; M G Oliver
Journal:  Am J Physiol       Date:  1991-02

Review 6.  Mucin-type glycoproteins.

Authors:  G J Strous; J Dekker
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

7.  A mucus-secreting human colonic epithelial cell line responsive to cholinergic stimulation.

Authors:  I Roumagnac; C Laboisse
Journal:  Biol Cell       Date:  1987       Impact factor: 4.458

8.  The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues.

Authors:  D J McCool; M A Marcon; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

9.  Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.

Authors:  J R Gum; J W Hicks; D M Swallow; R L Lagace; J C Byrd; D T Lamport; B Siddiki; Y S Kim
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

10.  Cl- secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6).

Authors:  K M Kreusel; M Fromm; J D Schulzke; U Hegel
Journal:  Am J Physiol       Date:  1991-10
View more
  11 in total

1.  A general role for Rab27a in secretory cells.

Authors:  Tanya Tolmachova; Ross Anders; Jane Stinchcombe; Giovanna Bossi; Gillian M Griffiths; Clare Huxley; Miguel C Seabra
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

Review 2.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

3.  Externalization of tropomyosin isoform 5 in colon epithelial cells.

Authors:  K V Kesari; N Yoshizaki; X Geng; J J Lin; K M Das
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  Probing mucin interaction behavior of magnetic nanoparticles.

Authors:  Vijayakumar N Boya; Renn Lovett; Saini Setua; Vaibhav Gandhi; Prashanth K B Nagesh; Sheema Khan; Meena Jaggi; Murali M Yallapu; Subhash C Chauhan
Journal:  J Colloid Interface Sci       Date:  2016-11-01       Impact factor: 8.128

6.  Roles of calreticulin and calnexin during mucin synthesis in LS180 and HT29/A1 human colonic adenocarcinoma cells.

Authors:  D J McCool; Y Okada; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

7.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 8.  Engineering the Mucus Barrier.

Authors:  T L Carlson; J Y Lock; R L Carrier
Journal:  Annu Rev Biomed Eng       Date:  2018-06-04       Impact factor: 9.590

9.  Stromal IFN-γR-signaling modulates goblet cell function during Salmonella Typhimurium infection.

Authors:  Pascal Songhet; Manja Barthel; Bärbel Stecher; Andreas J Müller; Marcus Kremer; Gunnar C Hansson; Wolf-Dietrich Hardt
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

10.  Effect of a Semi-Purified Oligosaccharide-Enriched Fraction from Caprine Milk on Barrier Integrity and Mucin Production of Co-Culture Models of the Small and Large Intestinal Epithelium.

Authors:  Alicia M Barnett; Nicole C Roy; Warren C McNabb; Adrian L Cookson
Journal:  Nutrients       Date:  2016-05-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.